Groowe Groowe / Newsroom / AVTX
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

AVTX News

Avalo Therapeutics, Inc. Common Stock

Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

globenewswire.com
AVTX

Avalo Therapeutics to Participate in Upcoming Investor Conferences

globenewswire.com
AVTX

Global Cancer Peptide Drug Market Report 2026: Opportunities, Approved Drug Dosage, Price, Sales & Clinical Trials Insights to 2031

globenewswire.com
LLY NVS AVTX

Form 8-K

sec.gov
AVTX

Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates

globenewswire.com
AVTX

Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates

globenewswire.com
AVTX

Avalo Therapeutics to Participate in the BTIG Biotechnology Conference

globenewswire.com
AVTX

Avalo Therapeutics to Participate in the Leerink Partners Therapeutics Forum

globenewswire.com
AVTX

Avalo Therapeutics to Join the Russell 2000® and Russell 3000® Indexes

globenewswire.com
AVTX

Form 8-K

sec.gov
AVTX